Underlying Medical Conditions Thyroid disorders, hormonal imbalances, chronic inflammation, and sleep apnea can reduce the bodys responsiveness to weight loss interventions, even when using GLP-1 drugs
Eden does not manufacture, prescribe, or distribute any medication
Its primary mechanism is VEGF upregulation, the growth of new blood vessels that supply oxygen and nutrients to injured tissue, alongside nitric oxide pathway modulation and fibroblast stimulation in tendon and ligament tissue
What the Evidence Supports for Lean Mass Preservation The good news is that the muscle loss associated with GLP-1 therapy is modifiable
Patients should maintain open communication with their healthcare team regarding pain management needs
It depends on which part of your optic nerve is affected